Bone Medical completes merger with Revenir

By Melissa Trudinger
Monday, 23 August, 2004

UK biotech company Bone Limited has completed its merger with Perth-based listed property management company Revenir (ASX: REV) after a successful capital raising of $2.5 million closed oversubscribed earlier in the month.

The company, which will be known as Bone Medical, is expected to start trading on August 31, 2004 under the stock symbol BNE.

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...

Maternal cannabis use puts kids at risk of behavioural problems

Children exposed to their mother's cannabis use during pregnancy and after birth are three...

Content from other channels on our network

Aussie manufacturing conditions improve at fastest pace since 2022

The engineering workforce is critical to securing Australia's future

The future of automation: Siemens SIMATIC S7-1200 G2

Study shows coal mine methane emissions much higher than reported

Boral secures grant for cement kiln carbon reduction

Norco's fresh full cream milk wins Canstar Blue award

Visy trials its new recyclable fibre-based thermal insulation

What's new on the shelf: new food products for Easter

Hygienic design for food production automation systems

Detection and Quantification of Lactose in Dairy Products

Wannon Water solves pump blockage issue

STABILISOR tech revolutionises air compressor operation

Kate Ceberano helps raise over $580,000 for clean water

Consult Australia Awards — winners announced

Land water loss causes sea level rise in 21st century